The AKT1 knockdown cells further showed significantly reduced BrdU incorporation in the presence of doxycycline when compared to the NT and AKT2 cells (Supplementary Figure S5D), confirming a role for AKT1 in cellular proliferation that is in line with the existing literature [17] and one mechanism of delayed primary tumor formation. The gene discussed is AKT2; the disease is neoplasm.